MEI Pharma Bets Big: $100M Litecoin Investment & Charlie Lee Joins Board

Biotech meets blockchain in a move that's raising eyebrows—and price targets. MEI Pharma just dropped a cool $100 million into Litecoin, doubling down on crypto while traditional investors still debate 'digital tulips.'

Litecoin's creator Charlie Lee isn't just cashing checks—he's taking a board seat. Because nothing says 'long-term commitment' like a founder returning to steer the ship after years of 'advisor' titles.

Wall Street analysts are scrambling to update spreadsheets, while crypto traders meme about 'diamond-hand biotech boomers.' Meanwhile, MEI's stock ticker might as well flash 'HODL' in neon.

One thing's clear: When pharma execs start allocating nine figures to proof-of-work coins, either the bull market's back—or someone's chasing the ultimate volatility high.